Psyence Biomedical PBM
NASDAQ PBM
$4.54 +0.30 (+7.08%)
As of: Oct 21, 2026 · 2:49 PM EDT

Psyence Biomedical (PBM) Convertible Debt (2024)

Updated

Psyence Biomedical (PBM) recorded Convertible Debt of $48,281 in the quarter ended Sep 30, 2024.

Analysis

Psyence Biomedical (PBM) Convertible Debt (2024) Analysis & Trends

As of Mar 31, 2024, Psyence Biomedical reported Convertible Debt of $7.66 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.26 Bn 1,105.84 Bn 19.71 Bn
2 Johnson & Johnson 618.12 Bn 536.65 Bn 17.26 Bn
3 AbbVie 503.25 Bn 476.36 Bn 12.70 Bn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn
5 Novartis Ag 298.45 Bn 262.44 Bn 11.24 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn
7 Amgen 237.30 Bn 192.70 Bn 7.24 Bn
8 Gilead Sciences 191.35 Bn 165.55 Bn 6.22 Bn
9 Pfizer 169.92 Bn 116.56 Bn 10.94 Bn
10 Psyence Biomedical 2.51 Mn -20.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 48,281.00
Mar 31, 2024 7.66 Mn
API Access

Psyence Biomedical Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=PBM&period=max&api_key=YOUR_API_KEY